All In Biotech

Investigational drug · Phase 3

su vaccine

Also called: RZV

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Herpes Zoster, Respiratory Syncytial Virus (RSV).

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 6, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

1 still active

All registered trials

43

Any phase or sponsor naming "su vaccine"

First trial start

2022

Aug 10, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "su vaccine", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Herpes Zoster
  • Respiratory Syncytial Virus (RSV)

Approved drugs for the same conditions: RSV · Herpes and shingles · Infectious disease and vaccines

Largest trials

Live from ClinicalTrials.gov: studies naming "su vaccine" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 385 on PubMed

Also in development for Herpes Zoster

  • CHO Cellrecombinant zoster vaccine, Recombinant Respiratory Syncytial Virus VaccinePhase 39 trials

    MAXVAX Biotechnology Limited Liability Company · Herpes Zoster, Respiratory Syncytial Virus (RSV), Herpes Zoster (HZ)

  • Sinovac Biotech Co., Ltd · Epidemic Meningitis, Meningococcal Vaccines, Herpes Zoster

  • SCTV04CRecombinant Herpes Zoster Vaccine -DosePhase 21 trial

    Sinocelltech Ltd. · Herpes Zoster

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from GSK.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.